Golean Detox US is recalling approximately 37 boxes of Golean DETOX capsules because FDA laboratory testing discovered the product contains sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was removed from the U.S. market in 2010 due to safety concerns regarding heart risks, while phenolphthalein is not approved in the U.S. because of its potential to cause cancer. The product was sold in 28-count boxes containing 14 individual packets and was distributed nationwide. Consumers should stop using this product immediately and contact their healthcare provider or pharmacist for guidance.
The product contains undeclared sibutramine, which can substantially increase blood pressure and heart rate, posing a significant risk to people with heart disease or high blood pressure. It also contains phenolphthalein, a chemical once used in laxatives that is no longer approved for sale in the U.S. due to concerns that it may cause cancer.
Full refund upon return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.